XML 30 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
United States Commodity Index Fund [Member]    
Cash Flows from Operating Activities:    
Net income (loss) $ 16,243,487 $ 2,873,099
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
(Increase) decrease in short-term investments 0 35,669,917
Unrealized (gain) loss on open futures contracts (18,150,103) 2,082,239
(Increase) decrease in dividends receivable (40,522) 0
(Increase) decrease in interest receivable 3,734 (34,098)
(Increase) decrease in directors' fees and insurance receivable 6,567 0
(Increase) decrease in ETF transaction fees receivable 0 350
Increase (decrease) in payable due to Broker 4,319,226 0
Increase (decrease) in management fees payable (64,671) 12,052
Increase (decrease) in professional fees payable (210,925) (128,912)
Increase (decrease) in directors' fees and insurance payable 0 7,381
Net cash provided by (used in) operating activities 2,106,793 40,482,028
Cash Flows from Financing Activities:    
Addition of shares 0 57,599,905
Redemption of shares (40,713,896) (4,261,429)
Net cash provided by (used in) financing activities (40,713,896) 53,338,476
Net Increase (Decrease) in Cash and Cash Equivalents (38,607,103) 93,820,504
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 478,509,213 426,097,875
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period 439,902,110 519,918,379
United States Copper Index Fund [Member]    
Cash Flows from Operating Activities:    
Net income (loss) 1,219,154 (1,206,325)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
(Increase) decrease in short-term investments 295,216 395,657
Unrealized (gain) loss on open futures contracts (1,436,100) 1,589,363
(Increase) decrease in receivable from Sponsor (21,919) (8,269)
(Increase) decrease in dividends receivable (2,286) 0
(Increase) decrease in interest receivable 160 (2,563)
(Increase) decrease in directors' fees and insurance receivable 0 35
Increase (decrease) in payable due to Broker 14,739 (442,429)
Increase (decrease) in management fees payable 428 1,477
Increase (decrease) in professional fees payable (13,175) (20,569)
Increase (decrease) in directors' fees and insurance payable 236 337
Net cash provided by (used in) operating activities 56,453 306,714
Cash Flows from Financing Activities:    
Addition of shares 5,451,099 4,174,486
Redemption of shares (1,651,189) 0
Net cash provided by (used in) financing activities 3,799,910 4,174,486
Net Increase (Decrease) in Cash and Cash Equivalents 3,856,363 4,481,200
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 12,116,244 7,922,175
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period 15,972,607 12,403,375
United States Commodity Index Funds Trust [Member]    
Cash Flows from Operating Activities:    
Net income (loss) 17,462,641 1,649,964
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
(Increase) decrease in short-term investments 295,216 36,164,341
Unrealized (gain) loss on open futures contracts (19,586,203) 3,660,316
(Increase) decrease in receivable from Sponsor (21,919) (19,168)
(Increase) decrease in dividends receivable (42,808) 0
(Increase) decrease in interest receivable 3,894 (36,907)
(Increase) decrease in directors' fees and insurance receivable 6,567 218
(Increase) decrease in ETF transaction fees receivable 0 350
Increase (decrease) in payable due to Broker 4,333,965 (442,429)
Increase (decrease) in management fees payable (64,243) 12,235
Increase (decrease) in professional fees payable (224,100) (165,362)
Increase (decrease) in directors' fees and insurance payable 236 7,762
Net cash provided by (used in) operating activities 2,163,246 40,831,320
Cash Flows from Financing Activities:    
Addition of shares 5,451,099 61,775,391
Redemption of shares (42,365,085) (4,261,429)
Net cash provided by (used in) financing activities (36,913,986) 57,513,962
Net Increase (Decrease) in Cash and Cash Equivalents (34,750,740) 98,345,282
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 490,625,457 435,476,532
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period $ 455,874,717 $ 533,821,814